In humans, the lacrimal gland (LG) is the primary contributor to the aqueous layer of the tear film. Production of tears in insufficient quantity or of inadequate quality may lead to aqueousdeficiency dry eye (ADDE). Currently there is no cure for ADDE. The development of strategies to reliably isolate LG stem/progenitor cells from the LG tissue brings great promise for the design of cell replacement therapies for patients with ADDE. We analyzed the therapeutic potential of epithelial progenitor cells (EPCPs) isolated from adult wild-type mouse LGs by transplanting them into the LGs of TSP-1 2/2 mice, which represent a novel mouse model for ADDE. TSP-1 2/2 mice are normal at birth but progressively develop a chronic form of ocular surface disease, characterized by deterioration, inflammation, and secretory dysfunction of the lacrimal gland. Our study shows that, among c-kit-positive epithelial cell adhesion molecule (EpCAM + ) populations sorted from mouse LGs, the c-kit
INTRODUCTION
Aqueous-deficiency dry eye (ADDE) is characterized by a lack of tear secretion from the lacrimal glands (LGs). ADDE affects millions of Americans, causing a debilitating loss of visual acuity, ocular surface irritation, and adverse lifestyle changes. In humans, the LGs are the primary contributor to the aqueous layer of the tear film, and many cases of ADDE, classified as aqueous surface dry eye, involve LG dysfunction and/or degeneration. One of the challenges of understanding the mechanism of human dry eye pathogenesis is the inability to perform biological and molecular studies before obvious clinical signs. As a result, the precise steps of disease development are not well understood. Currently there is no cure for advance cases of dry eye. Developing new therapies to restore LG function would drastically improve the quality of life of patients affected by ADDE. One possible new treatment option for ADDE is the use of stem/progenitor cells to induce LG regeneration. In many tissues (lung, muscle, brain, and heart), stem/progenitor cellbased therapies have been demonstrated to be viable approaches to treating diseases previously considered incurable [1] [2] [3] . Similar to other exocrine glands (pancreas, salivary, and mammary) [4] [5] [6] [7] , the "healthy" adult LG is highly regenerative and is able to repair itself, even after substantial damage [8, 9] . For example, a single injection of interleukin-1a (IL-1a) induces a severe inflammatory response, leading to destruction of LG acinar and epithelial cells, followed by epithelial cell proliferation and complete LG regeneration. In contrast, "diseased" chronically inflamed LGs that also show structural damage/destruction do not effectively repair [10] . The reason for this failure to repair is unclear, but may relate to chronic disruption of LG stem cell niche functions that are important to support stem cell-mediated regeneration. There is evidence that the adult LG epithelium contains both slow-cycling stem cells [11] and faster-cycling progenitor cells [12, 13] ; however, the roles of these cells in LG regeneration remain undefined.
Recently, replacement of an adult mouse LG with an embryonic LG-derived epithelio-mesenchymal reaggregate has been demonstrated [9] . However, obtaining human embryonic LGs would be a challenge, and they may not contain enough cells for adult LG restoration.
In this study, we report the isolation and characterization of putative epithelial cell progenitors (EPCPs) from adult uninjured
LGs. These cells expressed c-kit and markers of the epithelial cell lineage Runt-related transcription factor 1 (Runx1) and epithelial cell adhesion molecule (EpCAM). When grown in reaggregated three-dimensional (3D) cultures, EPCPs were able to differentiate into organoids containing multiple LG cell types. Moreover, when transplanted into injured LGs, EPCPs were able to engraft into acinar and ductal compartments.
We also tested the engraftment and function of EPCPs in the "diseased" LG using a recently reported model of ADDE-the thrombospondin-1 null TSP-1 2/2 (also known as Thbs-1 2/2 ) mouse. This model fully mimics the development of chronic autoimmune dry eye disease with loss of function preceding inflammatory cell infiltration [14] . Thrombospondin-1 is a component of the extracellular matrix that functions in cell-matrix and cell-cell interactions, regulation of cellular phenotype, and activation of latent transforming growth factor-b [15, 16] . Although born with no apparent abnormalities of the LG anterior segment, TSP-1
2/2
mice develop a severe inflammation of the LG with inflammatory infiltrates containing CD4 and CD8 T cells. Similar to Sjögren's syndrome (SjS) patients, both anti-SSA/Ro and anti-SSB/La autoantibodies are detected at elevated levels in TSP-1 2/2 mice sera, and a significant loss of LG secretory function is observed by 24 weeks [14] . Elevated levels of interleukins 17 and 6 and interferon g (IFNg) in the LG of 8-week-old TSP-1 2/2 mice are also observed.
Transplantation of EPCPs into a chronically inflamed
LG of the TSP-1 2/2 mouse restored the structural compartment of the "dis-
LG and increased tear secretion. This study provides new insight into LG progenitor cells that might be used in cell replacement therapy for degenerative dry eye diseases that still have no effective treatment.
MATERIALS AND METHODS

Mice
C57BL/6 (3-4 weeks old) mice were used for LG EPCP isolation and characterization. Donor and recipient mice were maintained in The Scripps Research Institute (TSRI) vivarium under standard conditions. Donor cells were isolated from Rosa26-LacZ (R26-LacZ) or Pax6-LacZ mice. R26-LacZ mice were generated by crossing R26-Cre and R26-LacZ flox/flox mice as described previously [17] . The Pax6-LacZ mouse was reported previously [18] . Mice used as recipients for EPCP transplantations were C57BL/6J (wild-type) and TSP-1 2 /2 mice that are a model of chronic
LG inflammation/destruction. 
Growth Medium
EpiLife (Thermo Fisher) was supplemented with Human Corneal Growth Supplement (catalog no. S-009-5, Thermo Fisher), 5 ng/ ml basic fibroblast growth factor (bFGF) (FGF2), 10 ng/ml epidermal growth factor (EGF) (R&D Systems Inc., Minneapolis, MN, https://www.rndsystems.com), and 10% FBS.
Differentiation Medium
Fitton-Jackson Modification (BGJb) was supplemented with GlutaMAX, 0.1% Lipid-Rich Bovine Serum Albumin (AlbuMAX I, catalog no. 11020, Thermo Fisher), insulin-transferrin-selenium (catalog no. 41400-045, Thermo Fisher), human transferrin (catalog no. 0030124SA, Thermo Fisher), and 5 ng/ml EGF (R&D Systems).
Immunostaining and Confocal Microscopy
LG sections, monolayer, and 3D cultures were stained by using an indirect sequential immunoenzymatic technique. Fig. 1A, 1B) . Control samples labeled with isotype control antibodies and with a single primary antibody were used to determine the background noise because of nonspecific antibody binding and to establish proper compensation for optimum separation between signals.
Preparation of 3D Reaggregated EPCP Cultures
EPCPs were isolated by FACS as described above. Isolated EPCPs were counted and dissociated in culture medium. A total of 1 3 10 5 to 1.5 3 10 6 cells in 50 ml of medium were drawn into a 100-ml pipette tip, and the tip was sealed with sterile parafilm. Cells were pelleted at 1,000g for 10 minutes and the cell plug/reaggregate then was inoculated into a 15-ml drop of laminin-111 (Trevigen, Gaithersburg, MD, https://www.trevigen.com) gel or Matrigel (BD Bioscience) resting on a polycarbonate filter and floating in serum-free medium (supplemental online Fig. 2 ).
Reverse-Transcriptase Profiler Polymerase Chain Reaction Array
Gene expression in sorted EPCPs (c-kit + dim/EpCAM + cells) were compared with isolated c-kit 2 /EpCAM + epithelial cells. RNA was isolated by using a RNeasy Mini kit (catalog no. 74104; SABiosciences, Qiagen, Valencia, CA, http://www.qiagen.com); cDNA was made by using an RT 2 First Strand Kit (catalog no. 330401; SABiosciences, Qiagen) and applied to the Mouse Stem Cell Transcription Factors RT 2 Profiler Array (Qiagen, PAMM-501Z). Quantitative reverse-transcriptase polymerase chain reaction was performed on the ABI 7300 system (Thermo Fisher), and data were analyzed by using online normalization and analysis tools (provided in the public domain, http:// sabiosciences.com/pcrarraydataanalysis.php). Three independent experiments were performed.
In Vitro Colony-Forming Efficiency Assay
Colony-forming efficiency (CFE) assays were performed by using FACS-isolated EPCPs and c-kit 2 /EpCAM + epithelial cells (control) or EPCPs that were maintained in either monolayer or 3D cultures for 3 weeks. Monolayer and 3D cultures were trypsinized to prepare a single cell solution before CFE assays. All cells were washed, filtered, counted, and centrifuged in 15-ml tubes at 300g for 10 minutes. The supernatant was removed, and cells were resuspended in an appropriate volume of culture medium by gentle pipetting to generate a single cell suspension as confirmed by microscopy. Cells were seeded at 1 3 10 3 cells per square centimeter into coated six-well dishes. The colonies were fixed at day 8 and stained with 10% methylene blue in 70% ethanol. The CFE was calculated as the number of colonies at day 8 as a proportion of the number of cells plated in a well. Colonies were manually scored under a stereomicroscope. The standard error of the mean was calculated for at least three independent experiments and at least three replicates for each experimental point.
Tear Production Measurement
Tear production was measured by using phenol red-impregnated cotton threads (Zone-Quick; Lacrimedics, DuPont, WA, http:// www.lacrimedics.com), as described previously [10, 20] . The threads were applied to the ocular surface in the lateral canthus for 10 seconds. Wetting of the thread (which turns red in contact with tears) was measured in millimeters. Tear volume was measured in both eyes of recipient mice before and after progenitor cell transplantations. Only females with reduced tear production (2.5 6 0.5 mm) were used in transplantation experiments.
EPCP Cell Transplantation
Sorted EPCP cells were pelleted and resuspended in Minimum Essential Medium a (a-MEM) (Corning). To analyze EPCP engraftment, we performed EPCP transplantation into injured LGs.
LGs of 3-to 4-month-old WT recipient mice were injured by a single IL-1 injection as described previously [10] . Donor EPCP cells were obtained by cell sorting from uninjured LacZ + LGs (see above) of 3-to 4-month-old WT mice and were transplanted into the recipient LGs 1 or 3 days after the injury. Approximately 4,000-5,000 cells in 3 ml of a-MEM were slowly injected into the LG of anesthetized mice by using a 28-G needle and a Microliter Syringe (Hamilton, Reno, NV, http://www.hamiltoncompany.com). Control LGs were injected with vehicle (a-MEM). Transplantation was repeated for a total of three independent experiments. Analysis of EPCP engraftment was carried out 40 days after transplantation. To analyze engraftment and function of EPCPs in the chronically inflamed LG of TSP-1 2/2 mice, we isolated EPCP from WT Pax6-LacZ + donor LGs as described above. Cells were injected into the LG of 6-to 8-monthold TSP-1 2/2 mice. Evaluation of EPCP engraftment was performed at 20, 40, and 80 days after transplantation.
Lacrimal Gland X-Gal Staining
Donor LGs were fixed with 1.25% paraformaldehyde and 1.25% glutaraldehyde solution and processed for 5-bromo-4-chloro-3-indolyl b-D-galactoside (X-Gal) staining as described previously [19] .
Histology, Cell Quantification, and Evaluation of Cell Engraftment Analysis of Cell Engraftment in IL-1a Injured LG
LGs stained with X-Gal were embedded in paraffin, and 5-to 10-mm sections were costained with Fast Red to visualize the nuclei. Slides were scanned with a Leica scanner (Leica Microsystems, Wetzlar, Germany, http://www.leica-microsystems.com). LGs were assessed at each time point in each of three independent experiments (i.e., in total 12 LGs [180 sections] were analyzed per time point). Quantification and measurement of inflammatory foci were performed by using a Leica DM4 B microscope and LAS X integrated imaging system.
Statistical Analysis and Data Presentation
Statistical analyses were performed by using Prism Software (GraphPad, San Diego, CA, http://www.graphpad.com). In bar graphs, data are presented as means 6 SD of replicates from a representative experiment or of the normalized data from several experiments. In the latter case, mean fold changes were calculated by first determining the ratio of the test condition over the appropriate control condition for each individual measurement, and then averaging these ratios. The unpaired two-tailed Student's t test and two-tailed Fisher's exact test were used to determine significance (p , .05) in the differences between data sets.
RESULTS
Isolation of Putative LG EPCPs by FluorescenceActivated Cell Sorting
We selected a panel of potential markers for LG progenitor cells based on existing publications. CD-117, also known as c-kit, is the receptor for stem cell factor, a cytokine involved in stimulating a variety of stem cells to cycle. Although c-kit was originally described on hematopoietic stem cells, this receptor is found on numerous stem cell types [21] [22] [23] [24] [25] . c-kit + cells restored function of irradiated salivary glands [26] and regenerated the prostate gland [27] . We assessed the distribution of c-kit + cells by immunostaining of whole LGs (Fig. 1A, 1B) using the c-kit antibody. At least three types of c-kit + cells were observed: small and large bright granular cells were scattered throughout the mesenchyme (Fig. 1A, 1B , large arrowheads), and small dim c-kit + cells were seen in the epithelium (Fig.  1A, 1B small arrowheads) .
To distinguish between epithelial and mesenchymal c-kit + cells, we used EpCAM. EpCAM is reported to mark undifferentiated and differentiated epithelial cells in multiple glandular tissues. Immunostaining of embryonic and adult LGs with the EpCAM antibody (Fig. 1C, 1D ) confirmed that EpCAM expression was restricted to the LG epithelial cell lineage. Similar to our immunostaining results, c-kit + dim and c-kit + bright cells were evident by flow cytometry ( Fig. 1E-1G ; supplemental online Fig. 2C ). The EpCAM antibody detected a single population of EpCAM + cells ( Fig. 1H-1J ; supplemental online Fig. 2D ).The isotype control antibodies showed no staining (Fig.  1G, 1J) . We also used antibodies to stem cell antigen 1 (Sca1) (expressed in multiple stem/progenitor cells), CD34 (hematopoietic and mesenchymal progenitor cell antigen), and CD45 (hematopoietic cell marker). In separate experiments, we also tested the antibody to CD31 (platelet endothelial cell adhesion molecule). The last three markers were used to exclude mesenchymal, hematopoietic, and endothelial cells. Once conditions for specific staining with a single antibody were determined (supplemental online Fig. 2C-2H ), we used combinations of antibodies for flow cytometry analysis. All cells in the c-kit + bright populations were EpCAM 2 , but CD45 + (Fig. 1K) Fig. 1L ; ,1% of total cells; yellow square). Further analysis of these cells (Fig. 1M ) using Sca1 and CD34 antibodies revealed that the only epithelial (EpCAM + ) cell population was negative for both of these markers (i.e., c-kit
of total cells]) (Fig. 1M, red square) . This cell population was also CD31-negative (data not shown). We hypothesized that c-kit
2 cells represent a putative LG EPCP population.
FACS-Isolated EPCP Cells Express Runx1 and the Pluripotency Factor Oct4
To further characterize EPCPs, we compared sorted EPCPs (c-kit
2 ) with c-kit 2 epithelial cells (comprised of partially differentiated and differentiated cells) (c-kit
2 ) for expression of stem cell transcription factors using the Stem Cell Transcription Factor Array (Qiagen). We found that EPCPs were highly enriched for pluripotency factor octamer-binding transcription factor 4 (Oct4: 5.8-fold increase; p = .004165), also known as POU5F1 (POU domain, class 5, transcription factor 1). Oct4 is frequently used as a marker for undifferentiated cells and is critically involved in the self-renewal of epithelial stem cells [28, 29] . Oct4 is also one of the reprogramming factors that allows somatic cells to be converted to induced pluripotent stem cells [30, 31] . In addition, putative EPCPs also expressed high levels of Runt-related transcription factor 1 (also known as acute myeloid leukemia 1 protein or core-binding factor subunit a-2) (3.6-fold; p = .000327) and vitamin D receptor (Vdr) (3.2-fold; 
Establishment of Mouse Epithelial Cell Progenitor Cultures With the Ability to Differentiate Into Secretory Cells
We previously showed that Pax6 is expressed during LG development in proliferating epithelial cells [18] . When plated, EPCPs formed small aggregates adherent to the substrate that showed multiple cell divisions. A subset of cells within each primary aggregate expressed Pax6 ( Fig. 2A, green) . In 5-7 days, the aggregates increased in size substantially, continued to express Pax6 (Fig. 2B , green), and also started to express other epithelial markers, such as E-cadherin (Fig. 2B, red) . In 2 weeks, the proportion of cells expressing Pax6 increased further (Fig. 2C, green) , and in 3 weeks, the cells spread throughout the plate (Fig. 2D, green) . This increasing proportion of Pax6 + cells is consistent with recent findings that in epithelium, Pax6 marks a highly proliferative population of committed transit amplifying progenitors [37] [38] [39] .
Next, we studied whether EPCPs could differentiate in culture. Replacement of growth medium with differentiation medium (medium with low EGF and bFGF content) induced differentiation as shown by Western blot analysis of the specific acinar differentiation marker Aqp5 (Fig. 2E, 2F ). We found that EPCPs cultured for 2-4 days had low levels of Aqp5 expression, whereas cells cultured for 7-14 days had relatively elevated Aqp5 expression (Fig. 2E,  2F ). These findings suggest that isolated EPCPs contain proliferating progenitor cells that can differentiate into secretory cells.
Reaggregated Cultures Preserve Colony-Forming Capability of EPCPs
LG-derived cell cultures show a decrease in cell proliferation over time, suggesting that the monolayer cultures do not support longterm progenitor cell survival/expansion. The cells within the intact LG are organized into three-dimensional (3D) structures [40, 41] . This 3D organization is critical for normal lung, cartilage, mammary gland, and many other organ progenitor cell functions [42] [43] [44] . We developed a simple and efficient technique for 3D culture of LG-derived EPCPs, which allowed enzymatically disaggregated EPCPs to regain cell-cell contacts by reaggregation (supplemental online Fig. 1 ). FACS-sorted EPCPs were dissociated in 50 ml of growth medium and drawn into a pipette tip, and the tip was sealed with parafilm. Cells were than pelleted, and the reaggregate was inoculated into a 15-ml drop of laminin-111 (Trevigen) gel or Matrigel (BD Bioscience) on a polycarbonate filter floating in growth medium. We reasoned that complex cell-cell and cell-matrix interactions in combination with growth factors might preserve the progenitor cell properties of EPCPs. We maintained these 3D cultures in parallel with monolayer control cultures for 3 weeks and then dissociated and seeded cells into six-well plates for in vitro colony-forming efficiency assays. Freshly isolated EPCPs were used as an additional control. The colonies were counted at day 8, and CFE was calculated as the number of colonies as of day 8 as a proportion of the number of cells plated (Materials and Methods). Both freshly isolated LG cells and the cells obtained from the 3D cultures formed five times more colonies (as a percentage of cells plated) than cells obtained from monolayer cultures (monolayer cultures = 1.09% 6 0.5%; p = .010241; freshly isolated cells = 5.58 6 1.11%, p = .001524; 3D cultures = 5.07% 6 0.89%, p = .005212) (Fig. 2G) . This experiment showed that reaggregated 3D cultures are able to preserve the progenitor properties of EPCPs.
Moreover, we tested whether cellular reaggregates could differentiate into branched structures in differentiation medium supplemented with FGF10. We found that reaggregated EPCP cultures formed primary buds in 48-72 hours (Fig. 2H) , and these buds expressed epithelial marker E-cadherin and stem cell marker Krt5 [19] (Fig. 2I) . Moreover, in 7-10 days these cultures formed well-distinguished ductal and acinar components (Fig. 2J, 2K ). This finding suggests that FACS-isolated EPCPs represent a progenitor cell population capable of undergoing branching morphogenesis.
Putative EPCPs Engraft Into Injured and "Diseased" LGs
To test the ability of EPCPs to engraft into injured LGs, we performed direct intraglandular transplantation of sorted EPCPs obtained from Pax6-LacZ mice [18, 45] into LGs of nontransgenic recipients (both recipient and donor mouse colonies had the same C57BL/6 genetic background). Before cell transplantation, the recipient LG was injured by IL-1a injection [10] , and sorted EPCPs were transplanted at 1 day (Fig. 3A, 3B ) or 3 days (Fig.  3C, 3D ) after the injury. Analysis of cell engraftment was carried out at 40 days after cell transplantation. In both cases (1 and 3 days after the injury), EPCPs injected into the LG were found in the ductal (Fig. 3A, 3B, 3D , black arrows) and acinar epithelial compartment (Fig. 3A-3D , white arrowheads). Control LGs injected with the vehicle did not show any LacZ + cells (Fig. 3E) . Interestingly, EPCPs transplanted into uninjured LGs showed no or minimal engraftment (data not shown). Moreover, cells injected 3 days after the injury (at the beginning of the LG regeneration phase) engrafted more efficiently (7.51% 6 0.73%, p , .001) than cells injected 1 day after LG injury (LG damage/inflammation phase) (1.43% 6 0.07%; p , .001) (Fig. 3F) . Thus, putative EPCPs were able to engraft into the LG epithelial compartment, and the efficacy of engraftment depended on the phase of LG regeneration.
Next, we studied whether EPCPs could restore "diseased"
LGs of the recently reported and relatively new model of ADDE-the TSP-1 2/2 mouse. Similar to SjS patients, SjS-specific autoantibodies were detected at elevated levels in the TSP-1 2/2 mice sera. TSP-1 2/2 mice also have elevated levels of interleukins and IFN-g, and, importantly, they gradually develop severe inflammation of the LG with infiltrates containing CD4 and CD8 cells, similar to humans with SjS [14, 46, 47] . Analysis of Tsp-1 expression pattern in the LG showed that Tsp-1 protein is expressed at the apical surface of ductal epithelial cells (supplemental online Fig. 3A, 3B ; white arrows) and in the elongated cells surrounding secretory acini (supplemental online Fig. 3A, 3B ). Fig. 3C, 3D , red arrows), but was found in the external layer of cells (most likely pericytes) surrounding large blood vessels (supplemental online Fig. 3D, white arrowhead) . Coimmunostaining with the a-smooth muscle actin (marker of myoepithelial cells) antibody showed that Tsp-1 was expressed in all myoepithelial cells (supplemental online Fig. 3E, 3F , yellow arrows). Analysis of TSP-1 2/2 mouse LGs showed that inflammation starts at approximately 10-12 weeks as periductal lymphocytic infiltrates (Fig. 3 , compare 3G and 3H; lymphocytic infiltrates are marked by black arrows), with severe inflammation and formation of large lymphocytic infiltrates evident by 6-8 months of age ( Fig. 3; compare Fig. 3G and 3H) . We wished to examine whether stem cell treatment could benefit advanced cases of dry eye disease and, in particular, whether donor cells could engraft and differentiate in these conditions. Hence, we used 8-month-old TSP-1 2/2 female recipient mice with advanced LG inflammation. The recipient mice were chosen based on tear secretion level: only TSP-1 2/2 mice with significantly decreased (2.5 6 0.5 mm) aqueous tear production were used (tear production was measured by using phenol-impregnated cotton threads as described in Materials and Methods). Sorted EPCPs obtained from Pax6-LacZ mice were injected into recipient LGs on one side, whereas the contralateral LG was injected with vehicle as a control. Analysis of cell engraftment and LG morphology was performed at 20, 40, 60, and 80 days after EPCP transplantation (12 recipient TSP-1 2/2 female mice per each time point were used in three independent experiments) ( Fig. 3K-3O ). At 20 days after transplant, LacZ-positive EPCPs were mostly incorporated into LG ducts (Fig. 3K) ; at 40 days after transplant, EPCPs were found in the ducts and differentiating LG acini (Fig. 3L) . At 60-80 days after transplant, LacZ-positive cells were present in the ducts and acini (Fig. 3M, 3N) . Comparison of stem cellinjected and control (saline-injected) LG morphology showed that density and size of LG inflammatory foci progressively decreased in EPCP cell-injected LGs, whereas density and size of foci in control LGs remained unchanged (compare Fig. 3K-3N with 3O ). Quantification of cell engraftment at 40 and 80 days after transplant indicated stable long-term donor engraftment (Fig. 4A) . At these stages, we observed a strong reduction in lymphatic cell infiltrations; we also observed the differentiation of LacZ-positive cells into secretory acini (Figs. 3M, 3N, 4B) . We compared numbers and sizes of infiltration foci in LG injected with EPCPs (40 and 80 days after transplant) or with saline using a two-tailed t test. (Fig. 4B) , revealing a significant reduction in inflammation in
LGs after EPCP transplantation. We also calculated the statistical significance of the differences in the number of large (.100 mm) and small (,100 mm) foci in experimental (40 and 80 days after EPCP cell transplantation) and control (salineinjected)
LGs using a two-tailed Fisher's exact test. The numbers of large and small foci in saline-and EPCP-injected (40 days after transplantation)
LGs differed, with p , .0001; saline-and EPCPinjected (80 days after transplantation) differed with p , .0001. Comparison of numbers of foci in the LG of EPCP-injected mice at 40 days versus 80 days after transplantation showed a significant difference, with p , .03. In addition, the cumulative area of inflammation (summed area of infiltration foci, measured in square micrometers) in these two EPCP-injected groups (40 and 80 days after transplantation) was compared with control saline-injected LGs. We found that EPCP-treated
LGs had substantial reduction of cumulative area of inflammation (Fig. 4C) . These tests indicate significant progressive improvement of the "diseased"
LG structure, particularly reduction in inflammatory foci, up to 80 days after EPCP transplantations.
EPCP Cell Transplantation Improves LG Function
We performed functional assessment of the tear production using phenol-red-stained cotton threads (Zone-Quick; Oasis Medical, Glendora, CA, http://oasismedical.com) as we described previously [14] . Estimation of tear production was performed at 0, 2, 4, 6, and 8 weeks after EPCP transplantation (Fig. 4D ) and compared with tear production in control saline-injected
LGs. At least six female mice per each time point and each treatment condition were used in each experiment, and the experiment was repeated three times. The two-tailed Fisher's exact test was used to identify significant differences between the mean values of experimental and control groups for each time point. This test showed significant differences in tear production between EPCP-and saline-injected (control) TSP-1 2/2 mice at 6 and 8 weeks after cell transplantation (Fig. 4D) . Comparison of saline-injected mice at 0-and 8-week time points showed no difference in tear production (p = .27), whereas comparison of EPCPinjected mice at 0-and 8-week time points showed a significant difference (increase) in tear production (p = .0002). The results suggest a significant progressive improvement of LG function after EPCP transplantation in an LG disease model.
DISCUSSION
Our studies suggest that mouse LG contains at least one putative EPCP (c-kit
that is able to engraft into the epithelial (acinar and ductal) component of injured/regenerating or "diseased" LG and restore LG structure and function. The c-kit receptor has been reported to mark epithelial progenitor-like cells during development of other glands, such as prostate and submandibular gland [27, 48] . During submandibular gland morphogenesis, highly proliferative distal buds contain progenitors expressing the c-kit receptor, which is critical for maintenance and expansion of small mucous granule embryonic progenitor cells [49] . Our study shows that the c-kit receptor is an important marker that identifies adult stem/ progenitor cells in LG epithelium. We showed that isolated LG EPCPs possess several important properties of stem/progenitor cells. EPCPs show elevated expression of stem cell markers Runx1, Oct4, Pax6, and Vdr; form colonies; and develop into LG organoids that differentiate into ductal and secretory compartments in 3D cultures. The important role of Pax6 for ocular progenitor cell function was reported in numerous publications [39, [50] [51] [52] [53] [54] [55] [56] . It has been reported that Oct4 is critical for self-renewal and maintenance of multiple stem and progenitor cell types, and Oct4 is downregulated in all differentiated somatic cell types in vitro and in vivo [57, 58] . In the corneal epithelium, Oct4 + cells were LG with advanced stage aqueous-deficiency dry eye. The data are mean number of inflammatory foci 6 SD from four or five mice. Statistical significance of differences between groups was calculated by using a two-tailed t test for groups with unequal variance and gave the following p values: saline-injected versus EPCP-injected (60 days after injection), p = 1.05658530891 3 10 2/2 mice) that received a single injection of EPCPs showed a significant increase in tear production at 4 weeks after transplantation. Tear production was measured in 18 mice per each time point and each condition in three independent experiments (six mice per experiment). The two-tailed Fisher's exact test was used to identify significant differences between the mean values of experimental and control groups for each time point. The p values for each time point were as follows: 0 weeks (p = 1), 2 weeks (p = 1), 4 weeks (p = .06), 6 weeks (p = .0002), and 8 weeks (p = .002). Asterisks indicate differences in tear production between day 0 and weeks 4, 5, and 6 after EPCP transplantations; *, p values are determined in the text above. Abbreviation: EPCPs, epithelial progenitor cells. mainly found in limbal and central corneal epithelial basal layers [57] . These reports are consistent with our data showing that, in contrast to EPCPs, differentiated epithelial cells of the LG have no or very little Oct4 expression. Enriched expression of the Runx1 transcription factor was also detected in isolated EPCPs. Runx1 is involved in stem cell specification, proliferation, and differentiation in various tissues [59] [60] [61] , and it influences tissue differentiation and homeostasis [60] . We previously showed that Runx1 is a marker of the LG epithelial (ductal and acinar) cell lineage [19, 62] during LG development and that Runx1 expression strongly increased during adult LG regeneration [19] . We also show that FACS-isolated EPCPs engraft only into epithelial but not the mesenchymal compartment of the LG, consistent with our hypothesis that EPCPs are epithelial lineage specific stem/progenitor cells.
In the LG acute injury model, transplanted EPCPs engrafted differently depending on the timing of transplantation after injury. The most efficient donor cell engraftment was observed when EPCPs were transplanted 3 days after injury, and they were less efficient at 1 day after injury. Zoukhri et al. previously reported that the most extensive inflammatory response in the IL-1a-injured LG was observed on the first and second day after injury, whereas LG remodeling/regeneration was most evident on day three after injury [10] . Thus, the state of the host LG is important for successful donor cell engraftment, and the latter is most efficient once inflammation has subsided and regeneration has begun. These findings could inform the development of successful LG repair strategies using stem/progenitor cells, and, in particular, they suggest that suppression of ongoing inflammatory processes may increase the effectiveness of stem cell treatments in chronically "diseased"
LGs.
Importantly, we showed for the first time that intraglandular transplantation of EPCPs could restore structure and function of the chronically "diseased" TSP1 2/2 LG. We recently showed that expression of important epithelial stem/progenitor cell markers is altered in the LGs of two mouse models of Sjögren's syndrome: nonobese diabetic and MRL-lpr/lpr mice during LG inflammation [63] . This finding suggests the importance of the LG state for stem progenitor cell function and the possible role of inflammation in suppressing regeneration. However, our present work shows that EPCP transplantation was effective, even for older mouse recipients with advanced LG inflammation. Transplanted cells were able to not only engraft into LG epithelial compartment, but also to partially restore the structural integrity of the LG acini and improve secretory function. We observed that, even in the areas with low numbers of the engrafted EPCPs, the density of infiltrating cells within the inflammatory foci decreased. We speculate that, as described for some other stem/progenitor cells [64, 65] , EPCPs might produce anti-inflammatory factors that reduce immune cell infiltration. These findings are promising for the development of stem cell therapies to treat LG diseases. Overall, our study shows that uninjured adult LGs contain epithelial cell progenitors that we define as EPCPs. These EPCP cells could successfully engraft into ductal and acinar compartments of "diseased" LGs and restore acinar structure. We also found that EPCPs could increase tear secretion in TSP-1 2/2 mice with chronic
LG dysfunction. Our work provides an important first step toward identifying and characterizing an epithelial-specific progenitor population able to restore function in the LG. Further analysis of the molecular mechanisms that define and regulate their function within normal and "diseased"
LGs could facilitate development of new cell-based treatments for dry eye and other LG conditions.
